Cargando…
Effects of soluble guanylate cyclase stimulator on renal function in ZSF-1 model of diabetic nephropathy
BACKGROUND: Diabetic nephropathy is associated with endothelial dysfunction and oxidative stress, in which the nitric oxide-soluble guanylate cyclase-cyclic guanosine monophosphate (NO-sGC-cGMP) signaling pathway is impaired. We hypothesize that sGC stimulator Compound 1 can enhance NO signaling, re...
Autores principales: | Hu, Lufei, Chen, Yinhong, Zhou, Xiaoyan, Hoek, Maarten, Cox, Jason, Lin, Ken, Liu, Yang, Blumenschein, Wendy, Grein, Jeff, Swaminath, Gayathri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794189/ https://www.ncbi.nlm.nih.gov/pubmed/35085251 http://dx.doi.org/10.1371/journal.pone.0261000 |
Ejemplares similares
-
A soluble guanylate cyclase activator protects from diabetic nephropathy beyond standard of care in the ZSF1 rat
por: Pullen, Steven S, et al.
Publicado: (2015) -
Soluble Guanylate Cyclase Stimulators in Heart Failure
por: Kansakar, Sajog, et al.
Publicado: (2021) -
The discovery and characterization of novel soluble guanylate cyclase stimulators
por: Masferrer, Jaime L
Publicado: (2015) -
Soluble Guanylate Cyclase Stimulator Vericiguat Enhances Long-Term Memory in Rats without Altering Cerebral Blood Volume
por: Nelissen, Ellis, et al.
Publicado: (2021) -
Activation mechanism of human soluble guanylate cyclase by stimulators and activators
por: Liu, Rui, et al.
Publicado: (2021)